Ilan Daskal

Track

Insider profile

Currently holds positions in Infineon Technologies Americas Corp, Bio Rad Laboratories Inc and Natus Medical Inc

Performance

Overall performance
1.1
Performance over holding periods
1.1
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Infineon Technologies Americas Corp Oct. 6, 2008 -
Chief Financial Officer, Executive Vice President Bio Rad Laboratories Inc April 6, 2019 -
Independent Director Natus Medical Inc March 19, 2020 -
Independent Director Ixia June 26, 2015 - April 18, 2017
Director TerraForm Global Inc March 30, 2016 - July 24, 2016
Chief Financial Officer - Designee and Executive Vice President Sunedison Inc April 4, 2016 - June 27, 2016
Chief Financial Officer, Executive Vice President Cepheid April 9, 2015 - Aug. 13, 2015
Ilan Daskal's trades of Viavi Solutions Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
350.22
Quantity 34,528
Value US$2,812,790
Transaction date
Sale
Price
34.66
Quantity 2,325 -45.9%
Value US$2,197,520
Transaction date
Sale
Price
367.76
Quantity 88,944 -19.5%
Value US$2,566,002
Transaction date
Sale
Price
17.43
Quantity 105,191 -91.2%
Value US$1,833,479
Transaction date
Sale
Price
17.42
Quantity 39,709 -25.6%
Value US$691,731
Transaction date
Sale
Price
17.84
Quantity 25,100 -13.9%
Value US$447,784
Transaction date
Proposed sale
Price
17.49
Quantity 170,000
Value US$2,973,005
Transaction date
Sale
Price
9.28
Quantity 82,095 -100.0%
Value US$761,842
Transaction date
Proposed sale
Price
9.28
Quantity 82,095
Value US$762,080
Transaction date
Sale
Price
27.46
Quantity 2,500 -22.4%
Value US$68,650
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-31 2026-08-31
PrS Proposed sale
34,528
350.22
US$2,812,790 		34,528 350.22 US$2,812,790
2026-08-31 2026-08-31
S Sale
2,325 -45.9%
34.66
US$2,197,520 		2,325 -45.9% 34.66 US$2,197,520
2026-08-31 2026-08-31
S Sale
88,944 -19.5%
367.76
US$2,566,002 		88,944 -19.5% 367.76 US$2,566,002
2025-12-03 2025-12-02
S Sale
105,191 -91.2%
17.43
US$1,833,479 		105,191 -91.2% 17.43 US$1,833,479
2025-12-03 2025-12-02
S Sale
39,709 -25.6%
17.42
US$691,731 		39,709 -25.6% 17.42 US$691,731
2025-12-03 2025-12-02
S Sale
25,100 -13.9%
17.84
US$447,784 		25,100 -13.9% 17.84 US$447,784
2025-12-02 2025-12-02
PrS Proposed sale
170,000
17.49
US$2,973,005 		170,000 17.49 US$2,973,005
2025-06-06 2025-06-04
S Sale
82,095 -100.0%
9.28
US$761,842 		82,095 -100.0% 9.28 US$761,842
2025-06-04 2025-06-04
PrS Proposed sale
82,095
9.28
US$762,080 		82,095 9.28 US$762,080
2025-05-27 2025-05-23
S Sale
7,716
5.00
₹38,580 		7,716 5.00 ₹38,580
2021-06-15 2021-06-11
S Sale
2,500 -22.4%
27.46
US$68,650 		2,500 -22.4% 27.46 US$68,650